Investors & Media
we hope you share our vision of novel cancer and GvHD therapies to help those in need. if you have invested in ziopharm, this section will give you the information and insight you need.
ZIOPHARM Oncology, Inc. is a biopharmaceutical company that is seeking to develop and commercialize a diverse portfolio of treatments for people with cancer and graft-versus-host-disease. Our focus is on the development of cell and viral-therapies using a suite of technologies that employing novel gene expression, control and cell technologies to deliver safe, effective and scalable therapies.